Literature DB >> 23055193

Pyruvate kinase M2 and its evolving role as a prognostic marker in systemic malignancies besides colorectal carcinomas.

Shailendra Kapoor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23055193     DOI： 10.1007/s13277-012-0528-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  7 in total

1.  Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level.

Authors:  Oh-Hyung Kwon; Tae-Wook Kang; Jeong-Hwan Kim; Mirang Kim; Seung-Moo Noh; Kyu-Sang Song; Hyang-Sook Yoo; Woo-Ho Kim; Zhi Xie; David Pocalyko; Seon-Young Kim; Yong Sung Kim
Journal:  Biochem Biophys Res Commun       Date:  2012-05-22       Impact factor: 3.575

2.  Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model.

Authors:  Wenhao Guo; Yu Zhang; Ting Chen; Yongsheng Wang; Jianxin Xue; Yonggang Zhang; Wenjing Xiao; Xianming Mo; You Lu
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-25       Impact factor: 4.553

3.  Prognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patients.

Authors:  Daniel Fatela-Cantillo; Antonio Fernandez-Suarez; Miguel Alonso Marin Moreno; Juan Jesus Puente Gutierrez; Jose Miguel Diaz Iglesias
Journal:  Tumour Biol       Date:  2012-01-10

4.  Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.

Authors:  Ivo Novotný; Petr Dítĕ; Milan Dastych; Anna Záková; Jan Trna; H Novotná; H Nechutová
Journal:  Hepatogastroenterology       Date:  2008 Jul-Aug

5.  Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer.

Authors:  Dipok Kumar Dhar; Steven W M Olde Damink; James Hal Brindley; Andrew Godfrey; Michael H Chapman; Neomal S Sandanayake; Fausto Andreola; Sybille Mazurek; Tayyaba Hasan; Massimo Malago; Stephen P Pereira
Journal:  Cancer       Date:  2012-08-01       Impact factor: 6.860

6.  Tumor M2-pyruvate kinase as tumor marker in exocrine pancreatic cancer a meta-analysis.

Authors:  Yogesh Kumar; Kurinchi Gurusamy; Vineet Pamecha; Brian R Davidson
Journal:  Pancreas       Date:  2007-08       Impact factor: 3.327

7.  Cyclosporine A inhibits breast cancer cell growth by downregulating the expression of pyruvate kinase subtype M2.

Authors:  Kai Jiang; Baoming He; Lihua Lai; Qingyun Chen; Yang Liu; Qingming Guo; Qingqing Wang
Journal:  Int J Mol Med       Date:  2012-05-09       Impact factor: 4.101
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.